Alnylam Pharmace. buy Needham & Company LLC
Summary
This prediction ended on 13.09.24 with a price of €235.90. The prediction had a final performance of 20.97%. Needham___Company_LL has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Needham___Company_LL has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Alnylam Pharmace. | 1.629% | 1.629% | 48.867% |
iShares Core DAX® | 1.061% | -0.453% | 35.608% |
iShares Nasdaq 100 | 2.615% | 4.747% | 20.718% |
iShares Nikkei 225® | 5.693% | 9.002% | 14.243% |
iShares S&P 500 | 1.433% | 3.156% | 14.073% |
Comments by Needham___Company_LL for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Needham___Company_LL for Alnylam Pharmace.
Stopped prediction by Needham___Company_LL for Alnylam Pharmace.
Alnylam Pharmace.
02.08.24
02.08.25
03.08.25
Alnylam Pharmace.
24.06.24
24.06.25
25.06.25
Alnylam Pharmace.
02.05.24
02.05.25
03.05.25
Alnylam Pharmace.
15.02.24
15.02.25
16.02.25
Alnylam Pharmace.
09.10.23
09.10.24
10.10.24
Alnylam Pharmace.
04.08.23
04.08.24
05.08.24